To buy shares in Tonix Pharmaceuticals Holding Corp. you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $40.07 to buy one share in Tonix Pharmaceuticals Holding Corp. (as of 16:00 18-Aug-2025). Which is a change of $-11.28 or -21.97% from the last closing price of $51.35.
How To Buy Tonix Pharmaceuticals Holding Corp. Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Tonix Pharmaceuticals Holding Corp.:
- Pick a stock broker (jump down to compare the best brokers for buying Tonix Pharmaceuticals Holding Corp. stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:TNXP)
- Choose the number of shares you want to buy (1 share currently costs $40.07)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Tonix Pharmaceuticals Holding Corp. stock in your account (this will show your profit and loss)
- Tonix Pharmaceuticals Holding Corp. is currently worth $351,249,450 based on the last closing price of $51.35 with 7,957,216 shares traded.
- The most recent Tonix Pharmaceuticals Holding Corp. daily high has been $53.55 and daily low $39.39.
- The Tonix Pharmaceuticals Holding Corp. stock price 52 week high has been $130 and the 52 week low $6.76.
Compare Brokers For Buying Tonix Pharmaceuticals Holding Corp. Stock
Is Now A Good Time To Buy Tonix Pharmaceuticals Holding Corp. Stock?
- Tonix Pharmaceuticals Holding Corp.’s EPS (earnings per share) are -39.4. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Tonix Pharmaceuticals Holding Corp.’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Tonix Pharmaceuticals Holding Corp. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.